4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-011955
CEO gave up 2,975 shares (to pay taxes)
- CEO acquired 9,467 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal CEO | 2025-05-01 | Option exercise | +9,467 | 1,482,799 | D | ||
| Walker Neal CEO | 2025-05-01 | Shares withheld for taxes | −2,975 | $1.38 | $4,106 | 1,479,824 | D |
| Derivatives | |||||||
| Walker Neal CEO | 2025-05-01 | Option exercise · Restricted Stock Units | −9,467 | 0 | D | ||
Loading xslF345X05/form4-05052025_040501.xml…